Τομείς ισχύος της ελληνικής φαρμακοβιομηχανίας σε αναζήτηση χρηματοδότησης – Το παράδειγμα του Ταμείου Ανάκαμψης & Ανθεκτικότητας
Sectors of strength of the Greek pharmaceutical industry in search of funding – The Recovery & Resilience Facility (RRF) paradigm
View/
Abstract
The pharmaceutical sector in Greece, Europe, but also globally, constitutes one of the most important sectors from an economic perspective, as it contributes considerably to the GDP of each country, as well as from a social perspective, with pharmaceuticals being an integral component of the health services offered to a nation’s citizens. In relation to the Greek reality, the pharmaceutical industry has seen, especially in recent years, a trend of considerable development of the domestic pharmaceutical sector. However, the radical changes effected generally in the administration of health costs, both public and private, have resulted in rearrangements and opportunities for the pharmaceutical sector. In accordance with the main conclusions of this paper, the in-clusion of the Greek pharmaceutical industry in financial programmes and the imple-mentation of certain important reforms in the field of health will lead to a considerable reduction of pharmaceutical expenditures and increase of sales.